Morphic Holding, Inc. (NASDAQ: MORF)

This investigation is for anyone who acquired securities in Morphic Holding, Inc. (NASDAQ: MORF) prior to September 22, 2023.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by failing to timely disclose to investors that the Company’s colitis drug, MORF-057, was not effective enough to receive FDA approval.

On September 22, 2023, Morphic issued a press release announcing publication of an abstract discussing the Company’s EMERALD-1 phase 2a primary results. The Company revealed disappointing results, including that “endoscopic improvement was achieved in 25.7% of patients at week 12,” which was less than the 41% shown by Entyvio. On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Morphic Holding, Inc. (NASDAQ: MORF) prior to September 22, 2023 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.